Continuation ECT: relapse prevention in affective disorders
- PMID: 7834255
Continuation ECT: relapse prevention in affective disorders
Abstract
Relapse rates after the acute treatment of affective disorders with drugs or electroconvulsive therapy (ECT) are high (often 50-95%), despite preventive pharmacotherapy. In practice, some patients receive continuation and maintenance ECT after successful treatment of the index episode with ECT. We reviewed the charts of patients with affective illnesses who received continuation ECT (C-ECT) in our inpatient service from 1985 to 1991. In 33 courses of C-ECT, mean intertreatment interval was 10.1 days and the average duration of treatment was 10 weeks. One-year follow-up was available for 21 patients. Seven (33%) patients relapsed and needed re-admission within 1 year. The relapse rate for the patients with delusional depression was 42%, lower than the 95% reported for patients with delusional depression maintained on continuation pharmacotherapy before the C-ECT program started in our facility. No single factor examined was a significant predictor of relapse except C-ECT, which exhibited a sustained prophylactic effect for the year after the index episode.
Similar articles
-
Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.J ECT. 2007 Mar;23(1):17-20. doi: 10.1097/01.yct.0000263255.98796.30. J ECT. 2007. PMID: 17435567
-
Maintenance ECT: indications and outcome.Convuls Ther. 1995 Mar;11(1):14-23. Convuls Ther. 1995. PMID: 7796063
-
Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.J ECT. 2008 Sep;24(3):183-90. doi: 10.1097/YCT.0b013e318177275d. J ECT. 2008. PMID: 18695624
-
Continuation therapy following ECT: directions for future research.Psychopharmacol Bull. 1994;30(3):501-21. Psychopharmacol Bull. 1994. PMID: 7878189 Review.
-
[Biological treatment of acute depressive episodes].Fortschr Neurol Psychiatr. 2007 Oct;75(10):617-27; quiz 628-30. doi: 10.1055/s-2007-959178. Fortschr Neurol Psychiatr. 2007. PMID: 17914677 Review. German. No abstract available.
Cited by
-
Pharmacotherapy to sustain the fully remitted state.J Psychiatry Neurosci. 2002 Jul;27(4):269-80. J Psychiatry Neurosci. 2002. PMID: 12174736 Free PMC article. Review.
-
Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).Pilot Feasibility Stud. 2016 Aug 3;2:38. doi: 10.1186/s40814-016-0080-0. eCollection 2016. Pilot Feasibility Stud. 2016. PMID: 27965856 Free PMC article.
-
Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia.Psychiatry Investig. 2018 Aug;15(8):829-835. doi: 10.30773/pi.2018.05.15. Epub 2018 Aug 9. Psychiatry Investig. 2018. PMID: 30086612 Free PMC article.
-
Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention.J ECT. 2008 Sep;24(3):179-82. doi: 10.1097/YCT.0b013e318185fa6b. J ECT. 2008. PMID: 18708943 Free PMC article.
-
Catatonia in autism: implications across the life span.Eur Child Adolesc Psychiatry. 2008 Sep;17(6):327-35. doi: 10.1007/s00787-008-0676-x. Epub 2008 Apr 21. Eur Child Adolesc Psychiatry. 2008. PMID: 18427869 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical